L. Biesert

927 total citations
32 papers, 702 citations indexed

About

L. Biesert is a scholar working on Molecular Biology, Hematology and Infectious Diseases. According to data from OpenAlex, L. Biesert has authored 32 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Hematology and 9 papers in Infectious Diseases. Recurrent topics in L. Biesert's work include Hemophilia Treatment and Research (10 papers), HIV Research and Treatment (7 papers) and Protein purification and stability (6 papers). L. Biesert is often cited by papers focused on Hemophilia Treatment and Research (10 papers), HIV Research and Treatment (7 papers) and Protein purification and stability (6 papers). L. Biesert collaborates with scholars based in Germany, United States and Austria. L. Biesert's co-authors include Wolfgang G. Bessler, Werner Scheuer, Horst Schwinn, Alfons Gierl, Ingelore Holz, Wolfram Zillig, Fabrizio Fabbrizzi, Thomas R. Kreil, Christoph Kempf and Ilka von Hoegen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and European Journal of Biochemistry.

In The Last Decade

L. Biesert

31 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Biesert Germany 17 256 185 160 97 88 32 702
A. Lippin United States 8 165 0.6× 139 0.8× 168 1.1× 28 0.3× 73 0.8× 16 555
B. Lambrecht Germany 14 248 1.0× 98 0.5× 186 1.2× 45 0.5× 51 0.6× 27 869
H. Dichtelmüller Germany 13 137 0.5× 122 0.7× 76 0.5× 14 0.1× 55 0.6× 23 421
Douglas P. Blackall United States 14 140 0.5× 48 0.3× 240 1.5× 17 0.2× 177 2.0× 47 590
F. A. C. van Engelenburg Netherlands 13 87 0.3× 69 0.4× 45 0.3× 18 0.2× 80 0.9× 14 477
A. Mühlbacher Austria 14 143 0.6× 321 1.7× 59 0.4× 203 2.1× 149 1.7× 26 826
D. Herbert Opi Australia 11 102 0.4× 78 0.4× 276 1.7× 30 0.3× 139 1.6× 20 706
Adriana Baz Morelli Australia 18 302 1.2× 149 0.8× 62 0.4× 39 0.4× 536 6.1× 31 1.0k
Samuele Calabrό United States 10 260 1.0× 129 0.7× 66 0.4× 24 0.2× 749 8.5× 11 1.0k
R Laub Belgium 13 88 0.3× 146 0.8× 263 1.6× 2 0.0× 48 0.5× 37 621

Countries citing papers authored by L. Biesert

Since Specialization
Citations

This map shows the geographic impact of L. Biesert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Biesert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Biesert more than expected).

Fields of papers citing papers by L. Biesert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Biesert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Biesert. The network helps show where L. Biesert may publish in the future.

Co-authorship network of co-authors of L. Biesert

This figure shows the co-authorship network connecting the top 25 collaborators of L. Biesert. A scholar is included among the top collaborators of L. Biesert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Biesert. L. Biesert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Casademunt, Elisabeth, et al.. (2012). The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics. European Journal Of Haematology. 89(2). 165–176. 58 indexed citations
2.
3.
Dichtelmüller, H., L. Biesert, Fabrizio Fabbrizzi, et al.. (2009). Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies. Transfusion. 49(9). 1931–1943. 74 indexed citations
4.
Grüber, Gerhard, Christoph Kannicht, L. Biesert, et al.. (2006). Characterisation of a novel high-purity, double virus inactivated von Willebrand Factor and Factor VIII concentrate (Wilate®). Biologicals. 34(4). 281–288. 33 indexed citations
5.
Bauman, Patricia, L. Biesert, H. Dichtelmüller, et al.. (2006). Critical factors influencing prion inactivation by sodium hydroxide. Vox Sanguinis. 91(1). 34–40. 18 indexed citations
6.
7.
Rabenau, Holger F., L. Biesert, Torben Dall Schmidt, et al.. (2005). SARS-coronavirus (SARS-CoV) and the safety of a solvent/detergent (S/D) treated immunoglobulin preparation. Biologicals. 33(2). 95–99. 30 indexed citations
8.
Josić, Djuro, Andrea Buchacher, Horst Schwinn, et al.. (2000). Manufacturing of a Prothrombin Complex Concentrate Aiming at Low Thrombogenicity. Thrombosis Research. 100(5). 433–441. 31 indexed citations
9.
Biesert, L., et al.. (1998). Solvent/Detergent Treatment of Human Plasma ‐ A Very Robust Method for Virus Inactivation. Validated Virus Safety of OCTAPLAS®. Vox Sanguinis. 74(S1). 207–212. 49 indexed citations
10.
Josić, Djuro, et al.. (1997). Issues in the development of medical products based on human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 694(2). 253–269. 16 indexed citations
11.
Biesert, L., et al.. (1996). Viral safety of a new highly purified factor VIII (OCTATE). Journal of Medical Virology. 48(4). 360–366. 10 indexed citations
12.
Biesert, L., et al.. (1995). OCTAPLAS: Eine virusinaktivierte Alternative zu gefrorenem Frischplasma. Transfusion Medicine and Hemotherapy. 22(Suppl. 1). 2–4. 2 indexed citations
13.
Horvat, Štefica, Lidija Varga‐Defterdarovič, Jaroslav Horvat, et al.. (1995). Synthesis and bioactivity studies of 1‐adamantanamine derivatives of peptides. Journal of Peptide Science. 1(5). 303–310. 4 indexed citations
14.
Biesert, L., et al.. (1995). Virus validation experiments on the production process of OCTAVI SDPlus. Blood Coagulation & Fibrinolysis. 6(Sup 2). S48–S54.
15.
Schwinn, Horst, et al.. (1995). Improved virus safety and purity of a chromatographically produced Factor IX concentrate by nanofiltration. Journal of Chromatography B Biomedical Sciences and Applications. 669(2). 187–196. 26 indexed citations
16.
Rübsamen‐Waigmann, Helga, Andreas Pfützner, & L. Biesert. (1993). [Effect of antiviral agents].. PubMed. 21(4). 106–10. 1 indexed citations
17.
Biesert, L., et al.. (1991). Biochemical and genetical analysis of AZT-resistant HIV-mutants.. PubMed. 74–80. 5 indexed citations
18.
19.
Rübsamen‐Waigmann, Helga, L. Biesert, Nikolaus Müller‐Lantzsch, et al.. (1988). Distinction between HIV-1 and HIV-2 infection using novel synthetic lipopeptide conjugates as antigens in enzyme immunoassays. Journal of Virological Methods. 22(2-3). 173–182. 15 indexed citations
20.
Zillig, Wolfram, et al.. (1982). DNA‐Dependent RNA Polymerases of Thermoacidophilic Archaebacteria. European Journal of Biochemistry. 122(3). 471–477. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Lippin Breakdown of academic impact, for papers by B. Lambrecht Breakdown of academic impact, for papers by H. Dichtelmüller Breakdown of academic impact, for papers by Douglas P. Blackall Breakdown of academic impact, for papers by F. A. C. van Engelenburg Breakdown of academic impact, for papers by A. Mühlbacher Breakdown of academic impact, for papers by D. Herbert Opi Breakdown of academic impact, for papers by Adriana Baz Morelli Breakdown of academic impact, for papers by Samuele Calabrό Breakdown of academic impact, for papers by R Laub
Rankless by CCL
2026